Activity-based probes and methods of their preparation and use

Details Activity-based probes and methods of their preparation and use Activity-based probes and methods of their preparation and use

2011-04-12

2011-04-12

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07923433

ABSTRACT:
The present invention provides compositions and methods for assessing profiles of catalytically active enzymes in compositions containing a plurality of proteins. In preferred embodiments, the enzyme is a hydrolase, most preferably a cysteine protease. The methods described herein use activity based probes (“ABPs”) that have an affinity moiety for directing the binding of the ABP to one or more catalytically active target enzymes, a reactive group for forming a covalent bond at an active site of the target enzyme(s), and a TAG (e.g., a detectable label, preferably a fluorophore). One or more ABPs may be combined with a protein-containing sample under conditions for binding and reaction of the ABP(s) with target enzyme(s) that are present in the sample. The resulting products may then be used to assess the active enzyme profile of the sample, and can be correlated to the presence, amount, or activity of one or more target enzyme(s) present in the original complex protein mixture.

REFERENCES:
patent: 6008373 (1999-12-01), Waggoner et al.
patent: 6127134 (2000-10-01), Minden et al.
patent: 6207397 (2001-03-01), Lynch et al.
patent: 2002/0086333 (2002-07-01), Gahunia et al.
patent: 2475653 (2003-09-01), None
patent: WO-98/36057 (1998-08-01), None
patent: WO-00/01666 (2000-01-01), None
patent: WO-00/23421 (2000-04-01), None
patent: WO-01/08710 (2001-02-01), None
patent: WO 01/77668 (2001-10-01), None
patent: WO 01/77684 (2001-10-01), None
patent: WO 02/063271 (2002-08-01), None
patent: WO-03/072528 (2003-09-01), None
patent: WO 2003/072528 (2003-09-01), None
Papanikos et al., “e-Ketocarbonyl Peptides: A General Approach to Reactive Resin-Bound Intermediates in the Synthesis of Peptide Isoteres for Protease Inhibitor Screening on Solid Support.” J. Am. Chem. Soc. 123: 2176-2181, (2001).
Wilbur et al, “Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability,” Bioconjugate Chemistry (2001), 12(4), 616-623.
Krantz A, et al, “Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases,”.Biochemistry. May 14, 1991;30(19):4678-4687.
Aladekomo, J. B. et al, “Excimer' Fluorescence. VII. Spectral Studies of Naphthalene and Its Derivatives.” Sciences, vol. 284, No. 1399 (Mar. 23, 1965), pp. 551-565.
Bergseid, M. et al., “Small Molecule-Based Chemical Affinity System for the Purification of Proteins, Biotechniques.” 29(5), 1126-1133, (2000).
Brömme, et al. “Human Cathepsin V Functional Expression, Tissue Distribution, Electrostatic Surface Potential, Enzymatic Characterization, and Chromosomal Localization.”Biochemistry38: 2377-2385, (1999).
Cull and McHenry, “Preparation of Extracts from Prokaryotes.” (inMethods in Enzymology, vol. 182, Guide to Protein Purification, edited by Murray P. Deutscher) pp. 147-238, (1990).
Daniel, S. G. et al., “FastTag™ Nucleic Acid Labeling System: A Versatile Method for Incorporating Haptens, Fluorochromes and Affinity Ligands into DNA, RNA and Oligonucleotides.” Biotechniques 24(3), 484-489, (1998).
Gottschling et al., “Cellular Solid-Phase Binding Assay and Mass Spectrometry for Screening of α4β7 Integrin Antagonists.” Bioorg. And Medicinal Chem. Lett. 11: 2997-3000, (2001).
Gibson et al., “Nonpeptidic αvβ3Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without Tagging.” Agnew. Chem. Int. Ed. 40: 165-169, (2001).
Kidd et al., “Profiling Serine Hydrolase Activities in Complex Proteomes.”Biochemistry40: 4005-15, (2001).
Leon et al., “Evaluation of Resins for on-bead Screening: A Study of Papain and Chymotrypsin Specificity Using Pega-Bound Combinatorial Peptide Libraries.” Bioorg. Med. Chem. Lett. 8: 2997-3002, (1998).
Orain and Bradley, “Solid phase synthesis of trypanothione reductase inhibitors—towards single bead screening.” Tetrahedron Lett. 42: 515-518, (2001).
Papanikos et al., “α-Ketocarbonyl Peptides: A General Approach to Reactive Resin-Bound Intermediates in the Synthesis of Peptide Isoteres for Protease Inhibitor Screening on Solid Support.” J. Am. Chem. Soc. 123: 2176-2181, (2001).
Porco, J.A., “Organic Synthesis Using Chemical Tags: The ‘Third Leg’ Parallel synthesis.” Comb. Chem. High Throughput Screening. 3(2) 93-102 (2000).
Smith and Bradley, “Comparison of Resin and Solution Screening Methodologies in Combinatorial Chemistry and the Identification of a 100 nM Inhibitor of Trypanothione Reductase.” J. Comb. Med. 1: 326-332, (1999).
Supplementary European Search Report for EP Application No. 03774762.3.
European Office Action dated Dec. 3, 2009 for EP App. No. 03774762.3-1211.
Office Action dated Jun. 11, 2010 for Canadian Application No. 2,501,831.

Affiliated with

Also associated with

Rating

Activity-based probes and methods of their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Activity-based probes and methods of their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activity-based probes and methods of their preparation and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2626370